Armata Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Armata Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ARMP
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0000921114
Board of directors
-
Daniel B. Gilmer · DirectorSince 2026
-
Deborah Birx · Director · Chief Executive OfficerSince 2023
-
Joseph M. Patti · DirectorSince 2023
-
Jules Haimovitz · DirectorSince 2023
-
Kostas D. Odysseas · DirectorSince 2023
-
Robin Kramer · DirectorSince 2023
-
Sarah J. Schlesinger · DirectorSince 2023
-
Todd C. Peterson · DirectorSince 2023
Chief executives
Deborah Birx
· Chief Executive Officer
Since July 2023
Board connections
4 of this board's directors also sit on 2 other boards.
- via Deborah Birx, Jules Haimovitz, Kostas D. Odysseas and Sarah J. Schlesinger
- via Kostas D. Odysseas
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | Deborah Birx Director, Officer (Chief Executive Officer) | Shares withheld for tax | −14,041 | $4.26 | $59,815 |
| Mar 14, 2026 | Kyme Pierre Officer (Chief Business Officer) | Shares withheld for tax | −1,030 | $10.54 | $10,856 |
| Mar 14, 2026 | Deborah Birx Director, Officer (Chief Executive Officer) | Shares withheld for tax | −4,919 | $10.54 | $51,846 |
| Jul 10, 2025 | Deborah Birx Director, Officer (Chief Executive Officer) | Shares withheld for tax | −13,637 | $2.27 | $30,956 |
| Mar 14, 2025 | Kyme Pierre Officer (Chief Business Officer) | Shares withheld for tax | −1,027 | $1.95 | $2,003 |
| Mar 14, 2025 | Deborah Birx Director, Officer (Chief Executive Officer) | Shares withheld for tax | −6,061 | $1.95 | $11,819 |
| Jul 10, 2024 | Deborah Birx Director, Officer (Chief Executive Officer) | Shares withheld for tax | −22,925 | $2.68 | $61,439 |
| Mar 14, 2024 | Rychlik Richard Officer (Corporate Controller and PFO) | Grant or award | +10,000 | — | — |
| Mar 14, 2024 | Deborah Birx Director, Officer (Chief Executive Officer) | Grant or award | +60,000 | — | — |
| Dec 21, 2023 | Deborah Birx Director, Officer (Chief Executive Officer) | Grant or award | +200,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.